Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences

Core Viewpoint - Lexicon Pharmaceuticals is actively engaging with investors through participation in multiple healthcare conferences in March 2026, indicating a focus on investor relations and potential growth opportunities in the biopharmaceutical sector [1]. Group 1: Upcoming Events - Lexicon Pharmaceuticals will participate in a fireside chat at the 2026 Leerink Partners Global Healthcare Conference on March 11 at 10:00 a.m. [1] - The company will also engage in 1x1 investor meetings at the 2026 Jefferies Biotech on the Beach Summit from March 10-11 and at the Barclays 28th Global Healthcare Conference from March 10-12 [1]. Group 2: Company Overview - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [3]. - The company has a pipeline of drug candidates in various stages of development, including neuropathic pain, hypertrophic cardiomyopathy (HCM), obesity, metabolic disorders, and other cardiometabolic indications [3].